Health Care & Life Sciences » Biotechnology | Bone Biologics Corp.

Bone Biologics Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
0.40
2,661.40
1,115.10
620.40
690.30
955.40
Total Accounts Receivable
-
75.00
-
-
-
-
Other Current Assets
-
89.50
425.90
80.50
105.20
85.30
Total Current Assets
0.40
2,825.90
1,541.00
700.90
795.50
1,040.70
Net Property, Plant & Equipment
-
11.60
5.80
0.20
0.10
0.10
Other Assets
-
983.90
-
-
-
-
Total Assets
0.40
3,821.40
1,546.80
701.10
795.70
1,040.70
ST Debt & Current Portion LT Debt
-
3,659.30
-
1,200.00
-
Accounts Payable
-
-
-
226.50
216.90
Other Current Liabilities
40.20
215.40
2,145.20
75.30
744.90
Total Current Liabilities
40.20
3,874.70
2,145.20
1,501.80
961.80
Long-Term Debt
-
3,645.20
5,082.80
7,563.00
8,229.70
Total Liabilities
40.20
7,519.90
7,227.90
9,064.80
9,191.50
Common Equity (Total)
39.80
3,698.50
5,681.10
8,363.70
8,395.80
Total Shareholders' Equity
39.80
3,698.50
5,681.10
8,363.70
8,395.80
Total Equity
39.80
3,698.50
5,681.10
8,363.70
8,395.80
Liabilities & Shareholders' Equity
0.40
3,821.40
1,546.80
701.10
795.70

About Bone Biologics

View Profile
Address
2 Burlington Woods Drive
Burlington Massachusetts 01803
United States
Employees -
Website http://www.bonebiologics.com
Updated 07/08/2019
Bone Biologics Corp. is an emerging growth company, which engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.